Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes.
Saved in:
| Title: | Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes. |
|---|---|
| Authors: | McAuliffe PF; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Evans KW; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Akcakanat A; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Chen K; Department of Bioinformatics and Computational Science, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Zheng X; Department of Bioinformatics and Computational Science, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Zhao H; Department of Bioinformatics and Computational Science, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Eterovic AK; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Sangai T; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Holder AM; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Sharma C; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Chen H; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Do KA; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Tarco E; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Gagea M; Department of Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Naff KA; Department of Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Sahin A; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Multani AS; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Black DM; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Mittendorf EA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Bedrosian I; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Mills GB; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Gonzalez-Angulo AM; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Meric-Bernstam F; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America. |
| Source: | PloS one [PLoS One] 2015 Sep 01; Vol. 10 (9), pp. e0136851. Date of Electronic Publication: 2015 Sep 01 (Print Publication: 2015). |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
